Clinical Pharmacokinetics, Safety, and Tolerability of a Novel, First-in-Class TRPV4 Ion Channel Inhibitor, GSK2798745, in Healthy and Heart Failure Subjects

被引：0
|
作者：
Navin Goyal
Pete Skrdla
Rosemary Schroyer
Subramanya Kumar
Disala Fernando
Anna Oughton
Nicola Norton
Dennis L. Sprecher
Joseph Cheriyan
机构：
[1] GlaxoSmithKline,GlaxoSmithKline Clinical Unit Cambridge
[2] Addenbrooke’s Hospital,undefined
[3] Cambridge University Hospitals NHS Foundation Trust,undefined
来源：
American Journal of Cardiovascular Drugs | 2019年 / 19卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：335 / 342
页数：7
相关论文
共 24 条
  • [21] Safety, Tolerability, and Pharmacokinetics of the Novel Hepatitis B Virus Expression Inhibitor GST-HG131 in Healthy Chinese Subjects: a First-in-Human Single- and Multiple-Dose Escalation Trial
    Li, Xiaojiao
    Liu, Yusi
    Yao, Hanxin
    Wang, Meng
    Gao, Lei
    Lou, Jinfeng
    Mao, John
    Wu, Wenqiang
    Zhou, Yixin
    Tang, Yanan
    Yan, Wenhao
    Hu, Yanbin
    Ding, Charles
    Chen, Shuhui
    Niu, Junqi
    Ding, Yanhua
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (05)
  • [22] SAFETY, TOLERABILITY, AND PHARMACOKINETICS ATER SINGLE AND MULTIPLE DOSES OF MK-5172, A NOVEL HCV NS3/4A PROTEASE INHIBITOR WITH POTENT ACTIVITY AGAINST KNOWN RESISTANCE MUTANTS, IN HEALTHY SUBJECTS
    Brainard, Diana M.
    Petry, Amelia
    Anderson, Matt S.
    Mitselos, Anna
    Laethem, Tine
    Heirman, Ingeborg
    Caro, Luzelena
    Stone, Julie A.
    Sun, Peng
    Panorchan, Paul
    Van Bortel, Lucas M.
    Iwamoto, Marian
    Wagner, John A.
    HEPATOLOGY, 2010, 52 (04) : 1216A - 1217A
  • [23] TOLERABILITY, SAFETY, AND PHARMACOKINETICS OF THE NOVEL PDE INHIBITOR ZSP1601 IN HEALTHY SUBJECTS: A DOUBLE-BLIND, PLACEBO-CONTROLLED FIRST-IN-HUMAN SINGLE-DOSE, MULTIPLE-DOSE ESCALATION AND FOOD EFFECT STUDY
    Li, Cuiyun
    Zhang, Hong
    Zhu, Xiaoxue
    Wu, Min
    Hu, Yue
    Li, Xiaojiao
    Li, Haijun
    Chen, Xiaoxin
    Peng, Yun
    Ding, Hua Yan
    Niu, Junqi
    HEPATOLOGY, 2019, 70 : 1360A - 1361A
  • [24] Safety, tolerability, and pharmacokinetics of the novel pan-phosphodiesterase inhibitor ZSP1601 in healthy subjects: a double-blinded, placebo-controlled first-in-human single-dose and multiple-dose escalation and food effect study
    Zhu, Xiaoxue
    Wu, Min
    Wang, Hong
    Li, Haijun
    Lin, Junjie
    Peng, Yun
    Hu, Yue
    Li, Cuiyun
    Ding, Yanhua
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2021, 30 (05) : 579 - 589
123